Cipla gets CDSCO panel green signal to conduct Paxlovid trials in India Roshni Dhar28 Feb 2022 12:10 PM ISTIn a significant development, drug-major Cipla has got a green signal from the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Health Bulletin 26/February/2022 Roshni Dhar26 Feb 2022 4:13 PM ISTHere are top health stories for the dayIndia fears for its children as thousands of MBBS students stuck in Ukraine Amid the growing...
Cipla gets CDSCO panel nod to conduct Indian trials of Paxlovid Dr. Divya Colin26 Feb 2022 12:06 PM ISTNew Delhi: In a significant development, drug-major Cipla has got a green signal from the Subject Expert Committee (SEC) of the Central Drugs Standard...
Submit in vitro data on safety of Ropivacaine HCL monohydrate delivery: CDSCO panel tells Cipla Dr. Divya Colin20 Feb 2022 12:30 PM ISTNew Delhi: In line with the pharma major Cipla's Phase III clinical trial data for the local anaesthetic drug Ropivacaine HCL monohydrate solution for...
Kedar Upadhye steps down as Cipla Global CFO Ruchika Sharma6 Feb 2022 10:45 AM ISTMumbai: Cipla has recently announced that Kedar Upadhye has, on February 4, 2022, resigned from the position of Global Chief Financial Officer and...
Cipla to acquire 32.49 percent stake in solar power firm AMP Energy Green Eleven Ruchika Sharma6 Feb 2022 10:15 AM ISTNew Delhi: Drug major Cipla has recently announced that the company has signed a pact to acquire 32.49 per cent stake in AMP Energy Green Eleven to...
Cipla Independent Director Naina Lal Kidwai resigns Ruchika Sharma27 Jan 2022 10:15 AM ISTMumbai: Cipla has recently announced that Ms. Naina Lal Kidwai, Independent Director of the Company has resigned from the position of...
Drug makers to add Itraconazole linked Photosensitivity in package insert: CDSCO panel Medical Dialogues Team16 Jan 2022 11:30 AM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO) has recommended that CDSCO may...
DCGI directs strict vigil on spurious Tocilizumab Injs distribution in India Medical Dialogues Team12 Jan 2022 5:13 PM ISTNew Delhi: Raising a safety alert, the Drugs Controller General of India, Central Drugs Standard Control Organisation (CDSCO) has directed all...
Can DCGI approved Molnupiravir bolster India's fight against COVID? Farhat Nasim3 Jan 2022 11:45 PM ISTNew Delhi: As countries prepare themselves to fight a possible 'next wave'. The new variant – Omicron has been making headline and a surge in Covid-19...
Health Bulletin 3/January/2022 Dr. Nandita Mohan3 Jan 2022 7:45 PM ISTHere are the Top Health stories of the dayIndia's Omicron count crosses 1,700-markNMC nod to DM cardiology course at PGIMS RohtakIn a major milestone...
13 pharma majors to launch anti-COVID drug Molnupiravir Medical Dialogues Team1 Jan 2022 7:36 PM ISTNew Delhi: Thirteen Indian pharmaceutical companies, including Torrent, Cipla, Sun Pharma, Dr Reddy's, Natco, Mylan, Hetero, Optimus will be...
